EUVIMEDEUVIMED entdecken
Crossref

Extrapleural Pneumonectomy

Syed S. A. Qadri, Alex Cale, Mahmoud Loubani, Mubarak Chaudhry, Michael Cowen

PLEURA · 2015

DOI: 10.1177/2373997515595219 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLEURA, 2015. Verfasst von Syed S. A. Qadri und 4 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Malignant pleural mesothelioma is a rare but complicated disease associated with very poor prognosis, despite all forms of treatment and almost 100% mortality after diagnosis.

Objectives

The use of extrapleural pneumonectomy (EPP) in the management of malignant mesothelioma has become controversial recently and appears to be a dying modality. This retrospective study aimed to review and compare our results with available literature.

Methods

Consecutive patients were reviewed from March 1999 to April 2011 who underwent EPP for malignant mesothelioma. Short- and long-term outcomes were analyzed retrospectively until February 2013.

Results

There were 30 consecutive patients who underwent EPP in 13 years. The majority of them were male (29 patients) with a mean age of 61 years (34-71 years). There was no in-hospital or 30-day mortality in this cohort, although Thoracoscore predicted 7.9% risk of in-hospital mortality. The overall median survival was 20 ± 24 months, which prolonged to 47.5 ± 24 months in patients who received trimodality treatment. Thirty-one percent of patients survived ≥4 years and 2 patients are still alive at 6 and 7 years postoperatively. Survival was significantly longer in epitheloid versus biphasic mesothelioma, right versus left pneumonectomy, age below 65 years, and with no N2 disease. Survival at 6, 12, and 18 months was 80%, 65%, and 55% in comparison with 65%, 52%, and 34%, respectively, in the Mesothelioma and Radical Surgery trial.

Conclusions

Epitheloid mesothelioma, right pneumonectomy, negative extrapleural lymph nodes, and age below 65 years are associated with prolonged survival. Extrapleural pneumonectomy has a role in the management of malignant mesothelioma in selected patients by experienced surgeons.

Zitieren

APA

Qadri, S. S. A., Cale, A., Loubani, M., Chaudhry, M., & Cowen, M. (2015). Extrapleural Pneumonectomy. PLEURA. https://doi.org/10.1177/2373997515595219

Vancouver

Qadri SSA, Cale A, Loubani M, Chaudhry M, Cowen M. Extrapleural Pneumonectomy. PLEURA. 2015. doi:10.1177/2373997515595219

BibTeX
@article{Qadri2015,
  author = {Qadri, Syed S. A. and Cale, Alex and Loubani, Mahmoud and Chaudhry, Mubarak and Cowen, Michael},
  title = {Extrapleural Pneumonectomy},
  journal = {PLEURA},
  year = {2015},
  doi = {10.1177/2373997515595219}
}
Kostenlos starten →